0.71%QQQQ 46.17 2.00%FRE 4.84 8.33%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Shares of APP Pharmaceuticals Inc. skyrocketed Monday after Germany's Fresenius SE said it will buy the U.S. generic drug maker for $3.7 billion in cash.
The stock gained $5.70, or 32 percent, to $23.52 after the opening bell.
The deal will boost the health care company's North American opportunities to market drugs administered intravenously. The company will pay $23 per share for Schamburg, Ill.-based APP Pharmaceuticals.
Additionally, Fresenius will pay a registered and tradable contingent value right that could result in as much as $6 a share, provided APP reaches adjusted pretax profit targets from 2008 to 2010, the companies said in a statement.
So far this year, shares of APP Pharmaceuticals have jumped 74 percent.
Fresenius shares lost 78 cents to $56.14.
Gold Gold has flatlined and is marginally higher this morning with the dollar marginally lower and oil marginally higher on continuing concern...
Britney Spears' manager announced that the pop singer will not perform this...
A group of suspected drug users arrested in Denver this weekend with methampheta...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
-0.08
0.32
